Caleb Rans

Contributing Writer https://www.oncologynurseadvisor.com

Caleb Rans is a clinical pharmacist and medical communications specialist with professional expertise in medical writing, editing, and contract clinical research. He holds a PharmD from the University of Alberta and presently resides in Vancouver, Canada. He currently works as an independent consultant for several news, CME, and pharmaceutical companies.

All articles by Caleb Rans

Genitourinary Cancer

nsRPLND Appears Safe, Effective in Low-Volume Metastatic Seminoma

Caleb Rans

February 23, 2023

Nerve-sparing retroperitoneal lymph node dissection appears safe and effective for patients with low-volume metastatic seminoma.

A doctor sits at his desk, working hard.

Chronic Myeloid Leukemia‎

British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia

Caleb Rans

October 23, 2020

The British Society for Haematology has published updated guidelines for the diagnosis and management of chronic myeloid leukemia in adults and children.

Hematologic Cancers

Clonal Hematopoiesis in Hematologic Malignancies, Bone Marrow Failure Syndromes, and Stem Cell Clones

Caleb Rans

September 7, 2020

Recent studies have better elucidated the link between clonal hematopoiesis and hematologic malignancies.

This fact sheet provides an overview of the updated ESMO clinical practice guideline for hereditary GI cancers.

Side-Effect Management

New ASCO Clinical Guidelines on Management of Cancer Cachexia

Caleb Rans

June 25, 2020

The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.

Current treatment strategies for immune thrombocytopenic purpura are centered on immunomodulation and decreasing platelet destruction

Lymphoma

Improving the Clinical Diagnosis and Classification of Gray Zone Lymphomas

Caleb Rans

September 26, 2019

Although gray zone lymphoma has distinct morphologic features, immunophenotyping can make classifying gray zone lymphoma challenging.

Next post in Lymphoma

Caleb Rans

All articles by Caleb Rans

nsRPLND Appears Safe, Effective in Low-Volume Metastatic Seminoma

British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia

Clonal Hematopoiesis in Hematologic Malignancies, Bone Marrow Failure Syndromes, and Stem Cell Clones

New ASCO Clinical Guidelines on Management of Cancer Cachexia

Improving the Clinical Diagnosis and Classification of Gray Zone Lymphomas

No Benefit With Upfront Rituximab and Autologous HSCT Consolidation for Aggressive Non-Hodgkin Lymphomas